Hemangiopericytoma: An analysis of 106 cases - ScienceDirect

Human Pathology

Volume 7, Issue 1, January 1976, Pages 61-82

Human Pathology

https://doi.org/10.1016/S0046-8177(76)80006-8 Get rights and content

Abstract

A series of 106 cases of hemangiopericytoma was analyzed. The neoplasms occurred principally in adults (median age, 45 years), were deep seated, and were most common in the thigh (27 cases) and the pelvic retroperitoneum (26 cases). A painless mass was the first symptom in 96 of the patients. The median size of the excised tumors was 6.5 cm. Surgical removal of the tumor was often complicated by hemorrhage because of marked dilatation of the vascular bed in the vicinity of the neoplasm, probably as the result of rapid exchange of blood from the arterial to the venous circulation within the tumor. Microscopically, benign and malignant forms could be distinguished. The latter were characterized by increased cellularity, prominent mitotic activity, and foci of necrosis or hemorrhage. Follow-up information was obtained in 93 cases. Seventy-one of the 93 patients were living (two with recurrence and four with metastasis), and 22 had died (13 as the result of recurrence or metastasis and nine from unrelated causes). Recurrence preceded metastasis in more than two-thirds of the patients with evidence of metastasis. The 10 year survival rate was 70 per cent. The morphologic differences from other mesenchymal tumors showing a hemangiopericytoma-like vascular pattern are discussed, and the close resemblance of hemangiopericytoma to richly vascular forms of fibrous histiocytomas and synovial sarcoma is emphasized. Congenital or infantile hemangiopericytoma is described as a separate entity having a distinctive microscopic pattern and behavior.

References (62)

HakalaT.R. et al.
Paravesical hemangiopericytoma
J. Urol.
(1970)
SuttonD. et al.
Angiography of hemangiopericytoma
Clin. Radiol.
(1967)
RobertsonP.W. et al.
Hypertension due to a renin-secreting renal tumor
Am. J. Med.
(1967)
MovatH.Z. et al.
The fine structure of the terminal vascular bed. IV. Venules and their perivascular cells (percicytes, adventitial cells)
Exp. Mol. Pathol.
(1964)
RhodinJ.A.G.
Ultrastructure of mammalian venous capillaries, venules and small collecting veins
J. Ultrastruct. Res.
(1968)
StoutA.P. et al.
Hemangiopericytoma. A vascular tumor featuring Zimmermann's pericytes
Ann. Surg.
(1942)
Armed Forces Institute of Pathology
O'BrienP. et al.
Hemangiopericytoma
Cancer
(1965)
McCormackL.J. et al.
Hemangiopericytoma
Cancer
(1954)
StoutA.P. et al.
Hemangiopericytoma of the omentum
Surgery
(1943)

KauffmanS.L. et al.

Hemangiopericytoma in children

Cancer

(1960)

TulenkoJ.F.

Congenital hemangiopericytoma: case report

Planst. Reconstr. Surg.

(1968)

StoutA.P.

Hemangiopericytoma. A study of twenty-five new cases

Cancer

(1949)

DingmanR.P.

Hemangiopericytoma: report of two cases-one of congenital origin

Plast Reconstr. Surg.

(1958)

StoutA.P. et al.

ColeH.M. et al.

Hemangiopericytoma

Arch. Dermatol.

(1955)

StoutA.P.

Tumors featuring pericytes Glomus tumor and hemangiopericytoma

Lab. Invest.

(1956)

SimonR. et al.

Perirenal hemangiopericytoma. A case associated with hypoglycemia

J.A.M.A.

(1964)

MitchellM.L. et al.

Control of hypoglycemia with diazoxide and hormones

Ann. New York Acad. Sci.

(1968)

CrockerD.W. et al.

Mesodermal tumors associated with hypoglycemia: review of the literature and report of a case

Ann. Surg.

(1965)

HowardJ.W. et al.

Retroperitoneal hemangiopericytoma associated with hypoglycemia and masculinization

Delaware Med. J.

(1956)

PaulladeJ.J. et al.

Hemagiopericytoma associated with hypolycemia

Am. J. Med.

(1968)

GenslerA. et al.

Giant benign hemangiopericytoma functioning as a arteriovenous shunt

J.A.M.A.

(1966)

ReynoldsF.C. et al.

Hemangiopericytoma of the lower extremity. A case report

J. Bone Joint Surg.

(1958)

FeldmanF. et al.

Primary thoracic hemangiopericytoma

Radiology

(1964)

BlenkinsoffW.K. et al.

Pedunculated hemangiopericytoma attached to the thoracic aorta

Thorax

(1966)

Thompson-BowlesL. et al.

Hemangiopericytoma in a resected thoracic aneurysm

Ann. Thorac. Surg.

(1965)

VidrineA. et al.

Hemangiopericy toma: five cases

Surgery

(1964)

KentK.H.

Hemangiopericytoma: report of a case with special reference to roentgeno-therapy

Am. J. Roentgenol

(1957)

AckermanL.V. et al.

Hemangiopericytoma of retroperitoneal space

J. Missouri Med. Assoc.

(1948)

MujahedA. et al.

Hemangiopericytoma: report of four cases with a review of the literature

Am. J. Roentgenol.

(1959)

Cited by (757)

Orbital primary solitary fibrous tumor: a proposed recurrence risk prediction model based on 92 cases
2023, Human Pathology
Orbital primary solitary fibrous tumors (OPSFTs) are rare. To further characterize the clinical and pathological features of OPSFTs, 92 cases of OPSFT were analyzed to develop a risk prediction model. OPSFTs were equally distributed between males (n = 45) and females (n = 47) with a mean patient age of 40.8 years (median 39 years; range 5–70 years) at initial diagnosis. The mean tumor size was 2.79 cm (median 2.5 cm). Microscopically, the tumor cells were irregularly arranged in spindle, ovoid, or round shapes with varying amounts of collagen and branching blood vessels. Immunohistochemical staining showed positive STAT6 nuclear expression in all cases, loss of CD34 expression in seven cases, and a mean Ki-67 label index of 5.25% (range 1%–30%). All patients were initially surgically resected and had a median follow-up of 99 months: 33 patients recurred, 6 of whom presented with multiple recurrences and 1 with distant metastases. A predictive model for the risk of recurrence based on tumor size, mitosis, Ki-67 label index, and dominant constituent cell (DCC) was developed based on our results. In conclusion, OPSFTs are rare but can be reliably diagnosed based on characteristic morphological features and STAT6 immunohistochemistry. The rate of local recurrence of orbital tumors tends to be higher than the rate of distant metastases, which can be predicted by a risk stratification model specific to orbital tumors. Long-term clinical follow-up is recommended as advanced disease is common.
Fibrous tumors, a sampler
2023, Ophthalmic Pathology: The Evolution of Modern Concepts
The fibroblast is the prototypical cell of connective tissue. It is ubiquitous and capable of producing a variety of ground substances including collagen, elastic tissue and reticular fibers, not to mention macromolecules like glycosaminoglycans. The lowly fibroblast has struck fear into the hearts of pathologists for generations by its ability to disguise its biological potential. Perhaps more than most nosologic entities, fibrous tumors highlight the ephemeral nature of medical taxonomy. When investigators in 2010 examined 163 fibrosarcomas diagnosed between 1960 and 2008, they reclassified 84% of them. This review examines major conceptual debates and advances in the field of fibrous tumor biology that impact the eye and ocular adnexa. The photograph gallery includes pathology of nodular fasciitis, fibrosarcoma, dermatofibrosarcoma protuberans, solitary fibrous tumor, undifferentiated pleomorphic sarcoma, fibromatosis, atypical fibroxanthoma, hypertrophic scar, and keloid.
My time with Franz Enzinger at the Armed Forces Institute of Pathology
2022, Annals of Diagnostic Pathology
By a set of curious chances, Dr. F.M.Enzinger went from being captured as a prisoner of war by the American Army in Normandy in 1944 to become Head of the Soft Tissue Department of the Armed Forces Institute of Pathology (AFIP) in Washington DC and a friend of one of the directors, Major General Joe M. Blumberg. The author relates how he worked under Enzinger from 1967 to 1970. Enzinger would review all the slides of referred consultation cases on alternate days and record his diagnoses on filing cards kept in his personal file which supplemented the computerised AFIP central file. Periodic reviews of the files allowed him to retrieve large numbers of recognised tumors and to study potential cases of previously undescribed entities. During his 31 years at the AFIP, Enzinger lectured widely, wrote numerous papers on recognised entities, co-authored with Dr. Sharon W. Weiss their famous text book and discovered the following 26 previously undefined soft tissue tumors: clear cell sarcoma, intramuscular myxoma, epithelioid sarcoma, extra-skeletal myxoid chondrosarcoma, fetal rhabdomyoma, extra-skeletal Ewing's sarcoma, spindle cell lipoma, fibroma of tendon sheath, angiomatoid (malignant) fibrous histiocytoma, cranial fasciitis of childhood, intravascular fasciitis, pleomorphic lipoma, neuromuscular hamartoma, epithelioid hemangioendothelioma, spindle cell hemangioma, fibro-osseous pseudotumor of the digits, plexiform fibrohistiocytic tumor, giant cell fibroblastoma as a juvenile form of dermatofibrosarcoma protuberans, ossifying fibromyxoid tumor, myolipoma of soft tissues, inflammatory fibrosarcoma, juxta-articular myxoma, atypical decubital fibroplasia, chondroid lipoma, sclerosing epithelioid fibrosarcoma, and lipofibromatosis. His last discovery, co-authored by some of his AFIP followers, was published in 2000. He died in 2006. The AFIP itself was “disestablished” only five years later, which will make it very difficult for any future pathologist to exceed Enzinger's astonishing record of 26 “new” tumor discoveries.
Isolated hemangiopericytoma of the conjunctiva
2022, American Journal of Ophthalmology Case Reports
Citation Excerpt :
Hemangiopericytoma is a rare, vascular tumor originating from the pericytes surrounding capillaries.1 They present as red or brown painless masses in the fifth decade of life and are usually encountered in ophthalmic pathology as orbital neoplasms.1 Its occurrence as a solitary conjunctival mass is very rare, with only four other cases reported in the literature.2–4
To report a unique presentation of hemangiopericytoma and discuss the clinical course, pathological features, and management of this tumor.
An otherwise healthy 54-year-old Caucasian female presented with a painless conjunctival mass. The lesion gradually enlarged over a three-week period and was unresponsive to corticosteroid treatment. The mass was surgically removed, and histopathologic findings were consistent with hemangiopericytoma.
Conjunctival hemangiopericytoma should be considered in patients with conjunctival lesions unresponsive to medical management. Surgical excision is diagnostic and therapeutic and is the strongest predictor of clinical course. Incompletely excised lesions are at a greater risk of local recurrence and subsequent metastasis. Given the neoplasm's malignant potential, patients should be followed in the outpatient setting.
Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis
2021, Pathology Research and Practice
Published risk stratification models of solitary fibrous tumor (SFT) have been associated with distant metastases outside the central nervous system (CNS), but have not been studied for tumors occurring in the CNS. In a retrospective review, we identified 72 cases of solitary fibrous tumor or hemangiopericytoma (HPC) diagnosed between January 2011 and December 2020 at our institution. The tumors involved the central nervous system (N = 17), thoracic cavity (N = 28), and extrathoracic sites (N = 27). The risk of local recurrence, distant metastasis, or death at 5 years was 57% (95% CI 23%, 76%) in the CNS, 24% (95% CI 2%, 41%) in the thoracic cavity, and 13% (95% CI 0%, 25%) in extrathoracic sites. By contrast, the risk of distant metastasis or death at 5 years was 13% (95% CI 0%, 29%) in CNS primaries, 5% (95% CI 0%, 14%) in thoracic primaries, and 14% (95% CI 0%, 27%) in extrathoracic primaries. Using the published 3- and 4-variable risk stratification models by Demicco et al., we retrospectively assessed our cases for risk of local recurrence, distant metastasis, and death. For tumors outside the CNS, we show that three- and four-variable risk stratification models were associated with recurrence-free survival in addition to the previously known association with distant metastasis (all P < 0.05). In contrast, inside the CNS, we show that neither risk model is a significantly associated with clinical behavior, and that WHO grade is likely the best available prognostic tool, though none of the differences were significant. The lack of significant differences can be likely explained by the younger median age (47 years vs 61 years) and smaller median tumor size (3.5 cm vs 5.6 cm), downgrading the risk stratification scores in CNS compared to non-CNS primaries. In conclusion, existing risk stratification models of SFT are not associated with clinical behavior for tumors arising inside the CNS, but are associated with local recurrence in addition to distant metastasis outside the CNS.
Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma
2020, Pathology
Solitary fibrous tumour (SFT) is well-described in the urinary tract, but malignant examples are rare. We studied our experience with high grade malignant SFT of the prostate to address the degree of histological and immunophenotypical overlap with sarcomatoid carcinoma and prostatic stromal sarcoma. Four cases were identified from the surgical pathology consultation archives. All available H&E stained sections were reviewed. Immunostains for STAT6, CAM5.2, NKX3.1, PAX-8, GATA3, high molecular weight cytokeratin (34BE12), p40, and p63 were performed on available material. Each case was evaluated by three separate SFT prognostic risk models based on clinicopathological features, and for features of ‘dedifferentiated SFT’. The patient's ages were 49, 55, 69, and 73 years. Three presented with symptoms of benign prostatic hyperplasia and one with haematuria. Tumour sizes were 5, 9, 13, and 13 cm. Mitotic rate ranged from 6 to 20 mitoses per 10 high power fields, and two cases showed abrupt transition from conventional SFT to areas with marked nuclear pleomorphism/anaplasia (i.e., ‘de-differentiation’). Immunophenotypically, all four cases had strong and diffuse nuclear reactivity for STAT6. For other markers, three of three had both focal PR and GATA3 nuclear expression (up to 30% of cells). One case with ‘dedifferentiated’ features showed expression of multiple epithelial markers, including EMA (focal), high molecular weight cytokeratin (focal), p63, and p40. In summary, malignant SFT may rarely occur in the prostate and may closely mimic sarcomatoid carcinoma or prostatic stromal sarcoma, both histologically and immunophenotypically. Consideration of the diagnostic possibility of malignant SFT, recognition of unexpected GATA3 and PR expression, and utilisation of monoclonal STAT6 immunohistochemistry facilitate appropriate diagnosis at this unusual anatomical site.

View all citing articles on Scopus

^*: The opinions or assertions contained herein are the private views of the authors and are not to be construed as being official or as reflecting the views of the Department of the Army or the Department of Defense.

^†: Chief, Soft, Tissue Division, Armed Forces Institute of Pathology, Washington, D.C.

^‡: Chief, Department of Pathology, Veterans Administration Hospital, Washington, D.C.

Copyright © 1976 Published by Elsevier Inc.